Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation

J Antimicrob Chemother. 2024 Jul 1;79(7):1697-1705. doi: 10.1093/jac/dkae171.

Abstract

Background: Daptomycin is widely used in critically ill patients for Gram-positive bacterial infections. Extracorporeal membrane oxygenation (ECMO) is increasingly used in this population and can potentially alter the pharmacokinetic (PK) behaviour of antibiotics. However, the effect of ECMO has not been evaluated in daptomycin. Our study aims to explore the effect of ECMO on daptomycin in critically ill patients through population pharmacokinetic (PopPK) analysis and to determine optimal dosage regimens based on both efficacy and safety considerations.

Methods: A prospective, open-label PK study was carried out in critically ill patients with or without ECMO. The total concentration of daptomycin was determined by UPLC-MS/MS. NONMEM was used for PopPK analysis and Monte Carlo simulations.

Results: Two hundred and ninety-three plasma samples were collected from 36 critically ill patients, 24 of whom received ECMO support. A two-compartment model with first-order elimination can best describe the PK of daptomycin. Creatinine clearance (CLCR) significantly affects the clearance of daptomycin while ECMO has no significant effect on the PK parameters. Monte Carlo simulations showed that, when the MICs for bacteria are ≥1 mg/L, the currently recommended dosage regimen is insufficient for critically ill patients with CLCR > 30 mL/min. Our simulations suggest 10 mg/kg for patients with CLCR between 30 and 90 mL/min, and 12 mg/kg for patients with CLCR higher than 90 mL/min.

Conclusions: This is the first PopPK model of daptomycin in ECMO patients. Optimal dosage regimens considering efficacy, safety, and pathogens were provided for critical patients based on pharmacokinetic-pharmacodynamic analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / pharmacokinetics
  • Critical Illness*
  • Daptomycin* / administration & dosage
  • Daptomycin* / pharmacokinetics
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Gram-Positive Bacterial Infections / drug therapy
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Monte Carlo Method*
  • Prospective Studies
  • Tandem Mass Spectrometry

Substances

  • Daptomycin
  • Anti-Bacterial Agents